The Claim
Among patients with gout, achieving a serum uric acid level below 0.36 mmol/L is associated with a mortality rate of 25.7 deaths per 1000 patient-years, while those who do not achieve this target have a mortality rate of 80.9 deaths per 1000 patient-years.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In people with gout, those who lower their blood uric acid below 0.36 mmol/L have a lower death rate per year compared to those who do not reach this level.
See the scientific wording
Among patients with gout, those who achieve a serum uric acid level below 0.36 mmol/L have a mortality rate of 25.7 deaths per 1000 patient-years, compared to 80.9 deaths per 1000 patient-years in those who do not reach this target, indicating a substantial difference in survival outcomes.
When uric acid levels stay too high, it forms sharp crystals in the blood that trigger immune cells to release a powerful inflammatory signal. This constant inflammation damages blood vessels, causes plaque buildup, and leads to heart attacks and strokes, which kill people faster.
What the research says
1 studyPeople with gout who keep their blood uric acid below 0.36 mmol/L die much less often each year than those who don’t — the study found exactly that, with clear numbers showing a big difference in survival.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.